Randomized controlled trial of digital cognitive behavior therapy for prenatal insomnia symptoms: effects on postpartum insomnia and mental health
| Autor: | Elissa S. Epel, Andrew D. Krystal, John Neuhaus, Aric A. Prather, Jennifer N. Felder |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Postpartum depression
Pediatrics medicine.medical_specialty Anxiety law.invention Randomized controlled trial Pregnancy law Sleep Initiation and Maintenance Disorders Physiology (medical) medicine Insomnia Humans Depression (differential diagnoses) Depressive Disorder Cognitive Behavioral Therapy Depression business.industry Postpartum Period medicine.disease Anxiety Disorders Mental health Mental Health Treatment Outcome Insomnia and Psychiatric Disorders Gestation Female Neurology (clinical) medicine.symptom business |
| Zdroj: | Sleep |
| ISSN: | 1550-9109 0161-8105 |
| DOI: | 10.1093/sleep/zsab280 |
| Popis: | Study Objectives To evaluate the effects of digital cognitive behavior therapy for insomnia (dCBT-I) delivered during pregnancy on subjective sleep outcomes, depressive symptoms, and anxiety symptoms through 6 months postpartum. Methods People up to 28 weeks gestation (N = 208) with insomnia were randomized to 6 weekly sessions of dCBT-I or standard care. We report follow-up data at 3 and 6 months postpartum. The primary outcome was insomnia symptom severity. Secondary sleep outcomes included global sleep quality and insomnia caseness. Mental health outcomes included depressive and anxiety symptom severity. We evaluated between-condition differences in change from baseline for each postpartum timepoint and categorical outcomes. Results dCBT-I participants did not experience significantly greater improvements in insomnia symptom severity relative to standard care participants, but they did experience higher rates of insomnia remission and lower rates of insomnia caseness at 6 months postpartum. dCBT-I participants experienced greater improvements in depressive symptom severity from baseline to both postpartum timepoints, and in anxiety symptom severity from baseline to 3 months postpartum. The proportion of participants with probable major depression at 3 months postpartum was significantly higher among standard care (18%) than dCBT-I (4%, p = 0.006) participants; this between-condition difference was pronounced among the subset (n = 143) with minimal depressive symptoms at baseline (18% vs 0%). Conclusion dCBT-I use during pregnancy leads to enduring benefits for postpartum insomnia remission. Findings provide strong preliminary evidence that dCBT-I use during pregnancy may prevent postpartum depression and anxiety, which is notable when considering the high frequency and importance of these problems. Clinical Trials: ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT02805998, NCT02805998. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|